MECHANISMS UNDERLYING VITAMIN K INDUCED HYPERBILIRUBINEMIA IN PREMATURE INFANTS.
D000082:Acetaminophen; D000083:Acetanilides; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D001663:Bilirubin; D004912:Erythrocytes; D005954:Glucosephosphate Dehydrogenase; D005965:Glucuronates; D005978:Glutathione; D006461:Hemolysis; D006801:Humans; D006932:Hyperbilirubinemia; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases; D010600:Pharmacology; D014116:Toxicology; D014812:Vitamin K
D000083:Acetanilides; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D005965:Glucuronates; D014812:Vitamin K; D000082:Acetaminophen; D005954:Glucosephosphate Dehydrogenase; D005978:Glutathione; D001663:Bilirubin; C508827:acetanilide
ACETAMINOPHEN; ACETANILIDE; ANALGESICS AND ANTIPYRETICS; BILIRUBIN; ERYTHROCYTES; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCURONATES; GLUTATHIONE; HEMOLYSIS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; PHARMACOLOGY; TOXICOLOGIC REPORT; VITAMIN K